During the past decade, IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Breast Cancer" (2 trials), "Urothelial Cancer" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado" in a lesser frequency.

Most popular intervention types in "IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado" are "Drug" (14 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (5 trials), "Placebo" (4 trials), "Amivantamab" (3 trials), "Pertuzumab" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado" are 11 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".